ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pregnancy and women’s health"

  • Abstract Number: 2412 • 2018 ACR/ARHP Annual Meeting

    Evaluating Gaps in Reproductive Health Knowledge Among Women with Rheumatic Diseases

    Mehret Birru Talabi1, Megan E. B. Clowse2, Susan J. Blalock3, Lan Yu4, Alaina Chodoff5 and Sonya Borrero4, 1Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, 3Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Medicine, University of Pittsburgh, Pittsburgh, PA, 5General Internal Medicine, UPMC, Pittsburgh, PA

    Background/Purpose: While women with rheumatic diseases may face considerable reproductive health challenges, few studies have objectively assessed what these women know about their reproductive risks.…
  • Abstract Number: 2440 • 2018 ACR/ARHP Annual Meeting

    Outcomes of Pregnancy Complicated By ANCA-Associated Vasculitis: A Retrospective Review

    Jennifer Strouse1, Melissa Swee2, Manish Suneja1 and Bharat Kumar3, 1Internal Medicine, University of Iowa, Iowa City, IA, 2Transplant Nephrology, University of Iowa, Iowa City, IA, 3Internal Medicine-Division of Immunology, University of Iowa, Iowa City, IA

    Background/Purpose: ANCA-Associated Vasculitis (AAV) is a small-vessel vasculitis that predominantly affects the kidneys, lungs, and sinuses, among other organs. It has been traditionally associated with…
  • Abstract Number: 1293 • 2017 ACR/ARHP Annual Meeting

    Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies

    Evelyne Vinet1, Paul R. Fortin2, Stéphanie Roberge3, Emmanuel Bujold4 and Nils Chaillet5, 1Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Infectious Diseases and Immunity Research Division, CHU de Québec-Université Laval Research Center, Québec, QC, Canada, 3Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada, 4Reproduction, mother and youth health, Centre Hospitalier de l'Université Laval (CHUL), Québec, QC, Canada, 5Département d’obstétrique et gynécologie et département de Médecine de famille et médecine d’urgence, Université de Sherbrooke, Sherbrooke, QC, Canada

    Background/Purpose: Pregnant SLE women are at increased risk of cesarean delivery compared to pregnant women from the general population. Yet, to date, no one has…
  • Abstract Number: 1294 • 2017 ACR/ARHP Annual Meeting

    Time to Pregnancy in Women with Systemic Lupus Erythematosus

    Meriem El bakali1, Sasha Bernatsky2, Christian A. Pineau3 and Evelyne Vinet4, 1Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Women diagnosed with systemic lupus erythematosus (SLE) during the reproductive period have fewer children than unaffected women. Multiple disease-related factors might influence family size…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology